PLD
37
2
KLAC
56
11
IVZ
48
6
PHM
46
2
SYF
76
-2
PBI
32
2
FDX
33
-11
NRG
37
5
LH
33
-2
EXR
31
-11
AIV
37
-3
NEM
41
9
EXPE
86
3
DVA
65
3
CINF
35
11
PCG
61
2
GM
57
2
MCHP
36
3
NAVI
33
-8
ES
26
14
PLD
37
2
KLAC
56
11
IVZ
48
6
PHM
46
2
SYF
76
-2
PBI
32
2
FDX
33
-11
NRG
37
5
LH
33
-2
EXR
31
-11
AIV
37
-3
NEM
41
9
EXPE
86
3
DVA
65
3
CINF
35
11
PCG
61
2
GM
57
2
MCHP
36
3
NAVI
33
-8
ES
26
14
Financhill
Back

Outlook Therapeutics 10K Form

Sell
16

OTLK
Outlook Therapeutics

Last Price:
$1.48
Seasonality Move:
25.75%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive OTLK News And Ratings

See the #1 stock for the next 7 days that we like better than OTLK

OTLK Financial Statistics

Sales & Book Value

Annual Sales: $8.1M
Cash Flow: $-19.5M
Price / Cash Flow: 0
Annual Sales: $-3.57
Price / Book: 0

Profitability

EPS (TTM): -10.77000
Net Income (TTM): $-94M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Outlook Therapeutics Earnings Forecast

Key Outlook Therapeutics Financial Ratios

  • The Interest Expense is -2.64% of Operating Income.
  • Per Share Earnings over the last 10 years have been positive in 7 years.

Outlook Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: OTLK
CUSIP: 69012T
Website: outlooktherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

OTLK Technical Analysis vs Fundamental Analysis

Sell
16
Outlook Therapeutics (OTLK) is a Sell

Is Outlook Therapeutics a Buy or a Sell?